Nanobusiness News

RSS

Graphene Nanochem Amasses $50 Million on UK's AIM

LOMIKO METALS INC. (the "Company") recently presented to the Richmond Club in Toronto, a network of wealthy individual investors, analysts and fund managers outlining details on the Lomiko and Graphene Labs Strategic Alliance announced February 15, 2013 and commenting on recent carbon purity tests.

5 Apr 2013

Cerulean Pharma to Discuss Pre-Clinical and Clinical Results of Nanopharmaceutical CRLX101 at AACR Meeting

Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that researchers will present both pre-clinical and clinical data on Cerulean's Phase 2 candidate, CRLX101, in sessions at the American Association for Cancer Research (AACR) Annual Meeting.

From Cerulean Pharma 5 Apr 2013

New Research Collaboration to Develop Next-Generation MEMS Devices

STMicroelectronics, a global semiconductor leader serving customers across the spectrum of electronics applications, has begun working with research partners to develop a pilot line for next-generation MEMS devices augmented with advanced technologies such as piezoelectric or magnetic materials and 3D packaging.

From STMicroelectronics 5 Apr 2013

ARM Cortex-A57 Processor to be Implemented on TSMC's 16-nm FinFET Process

Fulfilling the promise of performance and power scaling at 16 nanometers, ARM and Cadence today announced details behind their collaboration to implement the first ARM® Cortex®-A57 processor on TSMC's 16-nanometer (nm) FinFET manufacturing process.

From Cadence Design Systems 5 Apr 2013

Global Molecular, Atomic and Nanoscale Imaging Market Forecast to Grow at 6.8% CAGR to $4.4 Billion by 2017

The global molecular, atomic and nanoscale imaging market was nearly $3.1 billion in 2011 and nearly $3.2 billion in 2012. This market is expected to grow to $4.4 billion by 2017, a compound annual growth rate (CAGR) of 6.8% from 2012 to 2017.

3 Apr 2013

U.S. Nanotechnology Drug Delivery Market Forecast to Grow at 84.79% CAGR through 2016

Research activities in healthcare have changed significantly in recent years. There has been a paradigm shift away from blockbusters drugs to a more personalized medicine approach. The focus is being placed increasingly on formulating drugs based on the individual's unique genome and immune response.

2 Apr 2013

Quantum Dot Company, QD Vision, Closes $20 Million Round of Financing

QD Vision, Inc., manufacturer of Color IQ™ optical components for LCD applications, today announced it closed a $20 million round of financing that will be used to further expand high volume production capacity, and to fund long term company growth.

30 Mar 2013

Altair Nanotechnologies’ Revenues Decrease in 2012

Altair Nanotechnologies Inc. ("Altair") today reported financial results for the fourth quarter and the year ended December 31, 2012.

From Altair Nanotechnologies 29 Mar 2013

Fontinalis Partners Leads Growth Financing for Nano-C

Nano-C, Inc., a leading developer of nanostructured carbon for use in energy and electronics applications, today announces a growth financing, which was led by Fontinalis Partners and saw continued participation from existing investors. Terms of the transaction are not disclosed.

From Nano-C 28 Mar 2013